Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III

NCT01067339 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01067339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01067339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Completed
Start date
February 4, 2010
Completion date
November 30, 2015
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial dysfunction